AstraZeneca reports positive results from endometrial cancer therapy trial
The study’s dual primary endpoint was progression-free survival.
Oncolytics gears up for Phase III trial in HR+/HER2- breast cancer
DCT Tracker: The most explored endpoints in decentralised clinical trials
Mirati’s sitravatinib stumbles in Phase III NSCLC trial
Pharma industry mixed on outlook of decentralised trials
Pharma world braces for major changes in new era of AI
Analysis
View More
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Themes
View MoreShionogi starts Phase I trial of Covid-19 antiviral in Japan
The trial will assess the pharmacokinetics, safety, and tolerability of S-892216 in healthy adults.
More themes
Insights
View MoreWho’s hiring who? Hiring activity related to social responsibility increased by 10% in the pharmaceutical industry in Q3 2022
The global pharmaceutical industry experienced a 10% rise in new job postings related to social responsibility in Q3 2022 compared…
It’s a match! Connecting patients to clinical trials with AI
Netramark unveils ChatGPT-based clinical trial de-risking technology
Navigating uncertainty: How Covid-19 has changed the CRO and sponsor dynamic
Novavax employs AI-based dose selection for Covid-influenza vaccine trials